CTRI/2022/01/039444招募中2 期
Safety and efficacy of Nicorandil in Peripheral Vascular Disease: An exploratory randomized controlled trial
试验速览
- 阶段
- 2 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Newly diagnosed patients with intermittent claudication (according to Edinburgâ??s Claudication Questionnaire1 )- suggestive of Peripheral vascular disease
- •2.Patients already diagnosed as case of Peripheral vascular disease with clinical and radiological evidence suggestive of chronic limb ischemia/ PVD
- •3.Age > 18 years to 65 years
- •4.Pain involving either single limb or both lower limbs
排除标准
- •1.Acute limb ischemia
- •2.Acute on chronic limb ischemia
- •3.Patients with connective tissues disorders with vasculitis
- •4.Have a neurological condition other than that associated with their pain diagnosis which, in the opinion of the investigator, would interfere with their ability to participate in the study
研究者
相似试验
已完成
4 期
Clinical Efficacy and SAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary InterventionST Elevation Myocardial InfarctionPercutaneous Coronary InterventionNCT04665648Fudan University1,500
招募中
3 期
Effect of Nicorandil on contrast-induced nephropathycontrast-induced nephropathy.Nephropathy induced by other drugs, medicaments and biological substancesICD 10- N1IRCT20230110057096N1Rasht University of Medical Sciences264
进行中（未招募）
不适用
The effect of intracoronary nicorandil in improving coronary blood flow during primary angioplastyCTRI/2018/10/015937Dr Sreejith A G
已完成
不适用
the efficacy of nicorandil in percutaneouns coronary intervention post procedure MI studyAngina PectorisJPRN-UMIN000027846Tsukazaki Hospital Department of Cardiology100
已完成
不适用
To study the efficacy of Niconrandil drug as an add-on treatment to the standard care given to the patient with acute ischemic strokeCTRI/2022/01/039227SRMIST19